CONSOLIDATED BALANCE SHEETS (USD $)	Oct. 31, 2012	Jul. 31, 2012
ASSETS
Cash and cash equivalents	$ 37,031	$ 246,309
Other current assets	116,256	200,552
Total Current Assets	153,287	446,861
Property and Equipment, Net	118,776	704,678
Assets Held for Investment, Net	852,832	858,377
Patents, Net	2,561,090	2,634,458
TOTAL ASSETS	3,685,985	4,644,374
LIABILITIES AND STOCKHOLDERS' DEFICIENCY
Accounts payable and accrued expenses (Note 5)	7,777,732	7,015,652
Deferred revenue	242,356	263,125
Current maturities of long-term debt	156,596	1,222,746
Total Current Liabilities	8,176,684	8,501,523
Long-Term Debt, Net	0	441,415
Derivative Warrant Liability (Note 10)	4,347,710	4,081,627
Total Liabilities	12,524,394	13,024,565
Commitments and Contingencies (Notes 6 and 7)
Stockholders' Deficiency (Note 9):
Common stock, $.001 par value; authorized 750,000,000 shares at October 31, 2012 and July 31, 2012, respectively; 370,260,904 and 354,161,297 shares issued and outstanding at October 31, 2012 and July 31, 2012, respectively	370,261	354,161
Additional paid-in capital	348,396,471	348,099,813
Deficit accumulated during the development stage	(358,370,276)	(357,611,780)
Accumulated other comprehensive income	765,135	777,615
Total Stockholders' Deficiency	(8,838,409)	(8,380,191)
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIENCY)/EQUITY	3,685,985	4,644,374
Series A Convertible Preferred Stock [Member]
Stockholders' Deficiency (Note 9):
Preferred Stock Value	0	0
Series B Convertible Preferred Stock [Member]
Stockholders' Deficiency (Note 9):
Preferred Stock Value	0	0
Series C Convertible Preferred Stock [Member]
Stockholders' Deficiency (Note 9):
Preferred Stock Value	$ 0	$ 0